Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2024
Dermal Microcoring for Skin Laxity, Rhytides, and Scars.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hashemi David A, Tao Joy, Wang Jordan V, Munavalli Girish, Geronemus Roy G
Аннотация
BACKGROUND: Dermal microcoring extracts cores of skin that are small enough to allow healing in a scarless fashion. Its use has been reported in the treatment of skin laxity, rhytides, and textural abnormalities.
OBJECTIVE: To report the authors' clinical experience using dermal microcoring in a variety of cases.
MATERIALS AND METHODS: A retrospective chart review was performed looking at dermal microcoring cases for any indication between August 2022 and March 2024.
RESULTS: Thirty-eight patients were treated. Overall, 32 (84.2%) patients were women, with median age of 67 years (R: 20-80 years). Fitzpatrick skin types I to V were represented. Among patients with adequate photographs for review, improvements of grade 3 and 4 (good and excellent) were seen in 85.7% (n = 18/21) treated for skin laxity and rhytides, 50.0% (n = 3/6) treated for acne scars, 66.7% (n = 2/3) treated for traumatic or surgical scars, and 100.0% (n = 3/3) treated for foreign material. Six (15.4%) patients experienced erythema or hyperpigmentation lasting more than 4 weeks, and 2 (5.1%) patients experienced temporary focal scarring, which improved with intralesional therapy and laser treatment. No patients experienced permanent dyspigmentation, prolonged edema, or infection.
CONCLUSION: Dermal microcoring has been demonstrated to safely and effectively treat skin laxity, rhytides, scars, and foreign material.
OBJECTIVE: To report the authors' clinical experience using dermal microcoring in a variety of cases.
MATERIALS AND METHODS: A retrospective chart review was performed looking at dermal microcoring cases for any indication between August 2022 and March 2024.
RESULTS: Thirty-eight patients were treated. Overall, 32 (84.2%) patients were women, with median age of 67 years (R: 20-80 years). Fitzpatrick skin types I to V were represented. Among patients with adequate photographs for review, improvements of grade 3 and 4 (good and excellent) were seen in 85.7% (n = 18/21) treated for skin laxity and rhytides, 50.0% (n = 3/6) treated for acne scars, 66.7% (n = 2/3) treated for traumatic or surgical scars, and 100.0% (n = 3/3) treated for foreign material. Six (15.4%) patients experienced erythema or hyperpigmentation lasting more than 4 weeks, and 2 (5.1%) patients experienced temporary focal scarring, which improved with intralesional therapy and laser treatment. No patients experienced permanent dyspigmentation, prolonged edema, or infection.
CONCLUSION: Dermal microcoring has been demonstrated to safely and effectively treat skin laxity, rhytides, scars, and foreign material.